.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J06B_Immunoglobulins.J06BC04_Obiltoxaximab.Obiltoxaximab

Information

name:Obiltoxaximab
ATC code:J06BC04
route:intravenous
n-compartments2

Obiltoxaximab is a monoclonal antibody used for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis. It acts by binding the protective antigen component of anthrax toxin, inhibiting its entry into cells. It is approved for clinical use as an adjunct to appropriate antibacterial drugs.

Pharmacokinetics

Pharmacokinetic parameters are reported for healthy adult humans administered a single intravenous dose.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos